Invites Biocore Co., Ltd. (XKON:A216400) agreed to acquire 85% stake in PROCAGEN from Byun Seok-soo for approximately KRW 12,748 million on July 14, 2022. PROCAGEN generated Total assets of KRW 1,101 million, Total equity of KRW 993 million and Net Income of KRW -528 million for the financial year 2021. Transaction is expected to close on July 15, 2022.

Invites Biocore Co., Ltd. (XKON:A216400) completed the acquisition of 85% stake in PROCAGEN from Byun Seok-soo for approximately KRW 12,748 million on July 15, 2022.